
The Hidden Gem of Biotech: Why Summit Therapeutics Stands Out in a Shifting Market
Tech stocks’ dominance has waned, highlighting a shift towards resilient sectors like healthcare in 2025. Summit Therapeutics Inc. (NASDAQ:SMMT) emerges as a key player with its innovative approach to biopharmaceuticals. The company’s promising asset, ivonescimab, shows superior efficacy in trials against non-small